基于实验室指标的系统性红斑狼疮鉴别诊断列线图的构建及评估
杨婧偊, 陈留宝, 王康太, 杨兴智, 于海涛

Establishment and evaluation of nomogram for differential diagnosis of systemic lupus erythematosus based on laboratory indications
YANG Jingyu, CHEN Liubao, WANG Kangtai, YANG Xingzhi, YU Haitao
表1 训练集和验证集患者的6SLE主要危险因子比较
Tab 1 Comparison of six major risk factors for SLE in patients between training set and validation set
Risk factorTraining set (n=758)Validation set (n=312)P value
SLE groupControl groupSLE groupControl group
PRO
Pos227 (29.95)81 (10.69)87 (27.88)30 (9.62)0.999
Neg152 (20.05)298 (39.31)69 (22.12)126 (40.38)
Anti-dsDNA antibody (titer 1∶10)
Pos157 (20.71)10 (1.32)61 (19.55)5 (1.60)1.000
Neg222 (29.29)369 (48.68)95 (30.45)151 (48.40)
Anti-nRNP/Sm (titer 1∶100)
Pos179 (23.61)20 (2.64)51 (16.35)10 (3.21)0.274
Neg200 (26.39)359 (47.36)105 (33.65)146 (46.79)
ANA (titer 1∶100)
Pos342 (45.12)252(33.25)143 (45.83)108 (34.62)1.000
Neg37 (4.88)127 (16.75)13 (4.17)48 (15.38)
ANuA (titer 1∶100)
Pos128 (16.89)4 (0.53)52 (16.67)0 (0)1.000
Neg251 (33.11)375 (49.47)104 (33.33)156 (50.00)
Anti-P antibody (titer 1∶100)
Pos102 (13.46)6 (0.79)35 (11.22)2 (0.64)0.999
Neg277 (36.54)373 (49.21)121 (38.78)154 (49.36)